A New Indicator to Assess Stenosis Severity

Fractional Myocardial Mass to Assess Stenosis Severity

This study looked at the role of fractional myocardial mass (vessel-specific myocardial mass) in the assessment of stenosis physiological severity.

 

Researchers used CT angiography to study this new concept of myocardial mass subtended by a specific vessel, which could reduce anatomical-physiological mismatch.

 

The study included 463 patients with 724 lesions evaluated by multislice coronary computed tomography angiography and invasive coronary angiography with fractional flow reserve measurement (FFR).

 

Fractional myocardial mass was assessed based on arterial tree length and myocardial mass by CT.

 

FFR <0.80 was considered a functionally significant lesion and it was found in 39% of observed vessels. Fractional myocardial mass decreased consistently according to vessel caliber, which is obvious.

 

FFR <0.80 increased in direct proportion to fractional myocardial mass and inversely to angiographic minimal luminal diameter (p < 0.001).

 

Fractional myocardial mass and minimal luminal diameter showed good correlation with FFR (r=0.61) and resulted superior to stenosis diameter to predict FFR <0.80.

 

Optimal cutoff value for fractional myocardial mass/minimal luminal diameter was 29 g/mm with 75% sensitivity,   77% specificity and 77% diagnostic accuracy.

 

This relation could add information to the classical stenosis diameter to predict FFR<0.80.

 

 

Conclusion

The relation fractional myocardial mass / minimal luminal diameter could help discriminate functional compromise of vessels more accurately than anatomical stenosis. The concept of fractional myocardial mass could explain the discrepancy between anatomy and physiology.

 

Original Title: Physiological Severity of Coronary Artery Stenosis Depends on the Amount of Myocardial Mass Subtended by the Coronary Artery.

Reference: Hyung Yoon Kim et al. JACC Cardiovasc Interv. 2016 Aug 8;9(15):1548-60.

 

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...